We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$75.6B
AUM Growth
+$332M
(+0.44%)
Cap. Flow
-$1.48B
Cap. Flow
% of AUM
-1.96%
Top 10 Holdings %
Top 10 Hldgs %
9.2%
Holding
2,306
New
139
Increased
928
Reduced
1,013
Closed
118
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$234M |
| 2 |
eBay
EBAY
|
+$223M |
| 3 |
Walt Disney
DIS
|
+$189M |
| 4 |
Humana
HUM
|
+$184M |
| 5 |
DXC Technology
DXC
|
+$172M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$236M |
| 2 |
Citizens Financial Group
CFG
|
+$157M |
| 3 |
Applied Materials
AMAT
|
+$156M |
| 4 |
Huntsman Corp
HUN
|
+$154M |
| 5 |
STI
SunTrust Banks, Inc.
STI
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.77% |
| 2 | Technology | 16.07% |
| 3 | Industrials | 14.94% |
| 4 | Consumer Discretionary | 12.29% |
| 5 | Healthcare | 11.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Lincoln National
LNC
$8.73B
| $116M | 0.15% |
1,716,799
-1,234,091
| -42% | -$81.6M |
|
177
Parker-Hannifin
PH
$123B
| $115M | 0.15% |
721,906
-656,390
| -48% | -$104M |
|
178
Philip Morris
PM
$297B
| $115M | 0.15% |
981,915
+234,082
| +31% | +$27.1M |
|
179
Pultegroup
PHM
$24.1B
| $115M | 0.15% |
4,675,116
+3,645,638
| +354% | +$85.1M |
|
180
Constellation Brands
STZ
$22.2B
| $114M | 0.15% |
590,226
-118,714
| -17% | -$21.1M |
|
181
TE Connectivity
TEL
$59.6B
| $114M | 0.15% |
1,448,690
+347,181
| +32% | +$26.6M |
|
182
Kimberly-Clark
KMB
$36.3B
| $114M | 0.15% |
881,997
-37,328
| -4% | -$4.86M |
|
183
Charles River Laboratories
CRL
$11.2B
| $112M | 0.15% |
1,106,522
+1,427
| +0.1% | +$131K |
|
|
CELG
184
DELISTED
Celgene Corp
CELG
| $111M | 0.15% |
858,028
-53,516
| -6% | -$6.56M |
|
185
Textron
TXT
$14.7B
| $111M | 0.15% |
2,362,506
+274,844
| +13% | +$12.9M |
|
186
PVH
PVH
$4B
| $111M | 0.15% |
967,305
-694,568
| -42% | -$72M |
|
187
TD Synnex
SNX
$20.4B
| $110M | 0.15% |
1,827,192
-1,304
| -0.1% | -$73K |
|
188
Nu Skin
NUS
$252M
| $109M | 0.14% |
1,735,719
+76,451
| +5% | +$4.36M |
|
189
Vertex Pharmaceuticals
VRTX
$121B
| $109M | 0.14% |
843,884
+601,942
| +249% | +$72.5M |
|
190
Robert Half
RHI
$3.87B
| $108M | 0.14% |
2,259,840
+366,864
| +19% | +$17.2M |
|
191
Kroger
KR
$35.4B
| $108M | 0.14% |
4,626,166
+3,352,381
| +263% | +$95.1M |
|
192
Progressive
PGR
$123B
| $107M | 0.14% |
2,420,414
-110,625
| -4% | -$4.59M |
|
|
DST
193
DELISTED
DST Systems Inc.
DST
| $106M | 0.14% |
1,713,104
-59,812
| -3% | -$3.65M |
|
194
Accenture
ACN
$102B
| $106M | 0.14% |
853,108
-291,182
| -25% | -$35.5M |
|
195
Raymond James Financial
RJF
$33.8B
| $105M | 0.14% |
1,971,920
-234,601
| -11% | -$11.8M |
|
196
Nasdaq
NDAQ
$52.7B
| $105M | 0.14% |
4,407,072
-1,194,324
| -21% | -$27.5M |
|
197
Norfolk Southern
NSC
$75.4B
| $104M | 0.14% |
850,590
-466,463
| -35% | -$54.8M |
|
198
3M
MMM
$90.9B
| $103M | 0.14% |
593,051
-541,720
| -48% | -$90.6M |
|
199
Marvell Technology
MRVL
$168B
| $101M | 0.13% |
6,087,286
-1,292,443
| -18% | -$20.9M |
|
200
Jacobs Solutions
J
$15.9B
| $99.3M | 0.13% |
2,207,560
-1,000,008
| -31% | -$44.5M |
|
Similar funds
AQR Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, AQR Capital Management held 2,306 positions worth $75.6B, up 0.44% from $75.2B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
AQR Capital Management's Q2 2017 filing shows 139 new, 928 increased, 1,013 reduced and 118 closed positions. Its largest new stake was DXC Technology: 2,594,054 shares worth $172M. The largest sale was Wells Fargo, an estimated $236M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.
- AQR Capital Management's largest Q2 2017 buy was DXC Technology: 2,594,054 shares worth $172M.
- AQR Capital Management added most to Gilead Sciences in Q2 2017, an estimated $234M increase.
- AQR Capital Management's biggest Q2 2017 reduction was Wells Fargo, cutting an estimated $236M.
- AQR Capital Management fully exited Computer Sciences in Q2 2017, selling an estimated $77.8M.
- AQR Capital Management's ten largest holdings make up 9.2% of its $75.6B portfolio in Q2 2017.
- AQR Capital Management opened 139 new positions and closed 118 in Q2 2017.
- AQR Capital Management's portfolio value rose 0.44% quarter-over-quarter to $75.6B.
Based on AQR Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.